Submit Data |  Help |  Video Tutorials |  News |  Publications |  FTP Download |  REST API |  Citing RGD |  Contact   

ONTOLOGY REPORT - ANNOTATIONS


Term:negative regulation of cellular glucuronidation
go back to main search page
Accession:GO:2001030 term browser browse the term
Definition:Any process that stops, prevents or reduces the frequency, rate or extent of cellular glucuronidation.
Synonyms:exact_synonym: negative regulation of cellular glucuronide biosynthesis;   negative regulation of cellular glucuronide biosynthetic process;   negative regulation of cellular glucuronoside biosynthesis;   negative regulation of cellular glucuronoside biosynthetic process


show annotations for term's descendants       view all columns           Sort by:
 
negative regulation of cellular glucuronidation term browser
Symbol Object Name JBrowse Chr Start Stop Reference
G Ugt1a1 UDP glucuronosyltransferase 1 family, polypeptide A1 JBrowse link 1 88,211,959 88,220,002 RGD:2290270
G Ugt1a9 UDP glucuronosyltransferase 1 family, polypeptide A9 JBrowse link 1 88,070,779 88,220,002 RGD:9068941

Term paths to the root
Path 1
Term Annotations click to browse term
  biological_process 23163
    metabolic process 10979
      negative regulation of metabolic process 3168
        negative regulation of small molecule metabolic process 104
          negative regulation of cellular glucuronidation 2
Path 2
Term Annotations click to browse term
  biological_process 23163
    metabolic process 10979
      cellular metabolic process 9774
        organic acid metabolic process 1024
          oxoacid metabolic process 996
            carboxylic acid metabolic process 951
              monocarboxylic acid metabolic process 625
                uronic acid metabolic process 16
                  glucuronate metabolic process 16
                    cellular glucuronidation 15
                      regulation of cellular glucuronidation 3
                        negative regulation of cellular glucuronidation 2
paths to the root

NHLBI Logo

RGD is funded by grant HL64541 from the National Heart, Lung, and Blood Institute on behalf of the NIH.